We set out to leverage cutting-edge technology in biology and AI to produce quality proteins - sustainably.
Dr. Ruby Yu and Victoria Mo founded Terraferma with a bold vision: to revolutionize sustainable biomanufacturing. By harnessing the power of machine learning, they set out to dramatically reduce development time and cost, making large-scale biomanufacturing more viable than ever before.
With deep expertise at the intersection of synthetic biology and artificial intelligence, the founders are uniquely positioned to drive innovation and bring their mission to life. Alongside a passionate and talented team, they are shaping at Terraferma the future of biomanufacturing—one breakthrough at a time.
Meet our Team
Our Vision
We envision a world where human impact on the environment is minimized, and suffering is significantly reduced. At Terraferma, we believe that breakthrough innovation shouldn’t be confined to traditional science and technology sectors—it should extend to every industry, transforming how we create and consume.
By pioneering never-before-seen products with unmatched performance and sustainability, we are reshaping the future. Our purpose is to craft extraordinary experiences for our customers while fostering a more harmonious relationship between humanity and the planet.
Innovation with impact—that’s the future we’re building.
By pioneering never-before-seen products with unmatched performance and sustainability, we are reshaping the future. Our purpose is to craft extraordinary experiences for our customers while fostering a more harmonious relationship between humanity and the planet.
Innovation with impact—that’s the future we’re building.
Timeline
2022
Terraferma joins the S22 batch of YCombinator, the foremost incubator for fast-growing startups.
2022
Terraferma launches its first brand - Ten Lives, and immediately sells out of the first batch of pre-orders.
2023
Terraferma scales up to 10,000L of US production capacity.
2024
Terraferma increases protein yields by up to 9x with every iteration of their AI platform Proteogenius.